|
MTERFD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.322600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.524100E-02 |
| Normal-vs-Stage2 |
2.335200E-01 |
| Normal-vs-Stage3 |
9.620000E-01 |
| Normal-vs-Stage4 |
1.317960E-01 |
| Stage1-vs-Stage2 |
3.626000E-02 |
| Stage1-vs-Stage3 |
2.219200E-01 |
| Stage1-vs-Stage4 |
9.597800E-03 |
| Stage2-vs-Stage3 |
3.211800E-01 |
| Stage2-vs-Stage4 |
9.304600E-01 |
| Stage3-vs-Stage4 |
2.198400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.812600E-01 |
| Normal-vs-AfricanAmerican |
4.809600E-01 |
| Normal-vs-Asian |
8.188400E-01 |
| Caucasian-vs-AfricanAmerican |
2.640800E-01 |
| Caucasian-vs-Asian |
7.153600E-01 |
| AfricanAmerican-vs-Asian |
9.953000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.560800E-01 |
| Normal-vs-Female |
2.859800E-01 |
| Male-vs-Female |
4.347600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.459800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.275200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.100800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.043400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.141000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.588220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.140100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.103600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.941900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.670380E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.448400E-01 |
| Normal-vs-Grade 2 |
6.071800E-01 |
| Normal-vs-Grade 3 |
2.969400E-01 |
| Normal-vs-Grade 4 |
1.927030E-01 |
| Grade 1-vs-Grade 2 |
8.964000E-01 |
| Grade 1-vs-Grade 3 |
7.426000E-01 |
| Grade 1-vs-Grade 4 |
5.260600E-01 |
| Grade 2-vs-Grade 3 |
6.133400E-01 |
| Grade 2-vs-Grade 4 |
8.487600E-02 |
| Grade 3-vs-Grade 4 |
5.330300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.952300E-02 |
| Normal-vs-ccB subtype |
4.266800E-01 |
| ccA subtype-vs-ccB subtype |
2.728100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.897800E-01 |
| Normal-vs-N1 |
3.052200E-01 |
| N0-vs-N1 |
2.941800E-01 |
|
|
